Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2014 June;55(3) > The Journal of Cardiovascular Surgery 2014 June;55(3):335-8

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

REVIEWS  THE MANAGEMENT OF IN-STENT RESTENOSIS IN PERIPHERAL ARTERIES 

The Journal of Cardiovascular Surgery 2014 June;55(3):335-8

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

Management of in-stent restenosis in peripheral arteries: are DEBs sufficient as stand-alone treatment for femoro-popliteal in-stent restenosis?

Franzone A., Stabile E., Carbone A., Scudiero F., Trimarco B., Esposito G.

Division of Cardiology, Department of Advanced Biomedical Sciences, “Federico II” University, Naples, Italy


PDF


The treatment of in-stent restenosis (ISR) in the femoro-popliteal artery (FPA) is one of the major challenges of endovascular therapy, occurring in up to 40% of femoro-popliteal lesions treated with bare-metal stents within 1 year of treatment. Drug-eluting technologies, involving local delivery of paclitaxel, are providing a new paradigm for the treatment of ISR. Preliminary experience shows promising results compared to other techniques such as cutting balloon angioplasty and debulking strategies. Based on available data, drug-eluting balloons (DEBs) seem sufficient as stand-alone treatment of FPA-ISR. However, larger evidence from randomized studies is warranted to identify the clinical and/or anatomical setting in which they could fail.

inizio pagina